214360-82-4Relevant academic research and scientific papers
COMPOUNDS AS MODULATORS OF TLR2 SIGNALING
-
Paragraph 0220; 0222, (2019/10/23)
The present disclosure relates to compounds, pharmaceutical compositions comprising such compounds, and use of such compounds in methods of treatment or in medicaments for treatment of inflammatory diseases and certain neurological disorders that are related to inflammatory signaling processes, including but not limited to misfolded proteins.
IRE-1A INHIBITORS
-
Page/Page column 119, (2009/01/24)
Compounds which directly inhibit IRE-lα activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are useful for treating diseases associated with the unfolded protein response and can be used as single agents or in combination therapies.
